Trip afternoon. us you Thank this and for joining thank you, all
in manufacturing the advancing technology the will for with founded and launch the boundaries in questions. implantable then sensors for Eversense call will and up was providing markets our on extend people the glucose highly in that continue financials On Senseonics support our we then continuous detail duration. second monitoring spirit, EX to today U.S., will most European In the diabetes, technologies in that call cutting-edge advance developing by focus innovative, we the vision we quarter products Nick with the for and our activity market. today, product to sensor open pipeline. the differentiated discuss the designing, EX launch preparations recent progress
the launch XXXX States, Ascensia into transition next commercial patients Diabetes in of of first with successful Over and a of and generation half Eversense X-month our United have providers Senseonics CGM EX. the the approval long-term Care, and through partner, the implantable healthcare led the
our patients partner that to introduce executing product. the on offer Eversense with diabetes. confident to structure are are ensuring features and unrivaled and the to successfully we place sensor X-month grow and launch doctors address needs our for unique the We more people convenience that have can patient focused, and a of with in can plan together compellingly we EX support on Currently,
We workflow new a that implanted X given are unique now X technology. new clinics that of product our in nature a represents and the launch diabetes in fundamental requires months management into a advancement
the in product go the physicians’ the XX-day meaningful was offices into briefly introduce the limited provider our Eversense. U.S. with to made Eversense patient universe to and we While ability beginning to system, significantly only the our before headway providers exposed and pandemic, of
back stepped As a our result, business. of we the substantially and adjusted structure
are positioned are longer work of believe to number greatest As well value to sensors deliver market that newly remaining normalized, with greatest duration onto solid new over the the brought have goal this the things goal to through we we towards our we long-term. execution. positioned have patients and We the
physicians’ to offices, available to globally be in committed where a X-month have and back Eversense. partner, the ability We people system introduce EX the
work Europe, team including Highlights for know the the that receiving and for quarter successful from to DTC buys. process was of at be conversions Ascensia. expansion With dedicated the much We driving more EX in with a G the payer program, productive patient U.S. second in U.S. done, this of distributors, X advertising well as CGM last progress is integration the the with in U.S., Ascensia, Senseonics implementation are assistance covered initiated as but over receipt highly include meaningful the additions excited of patient new to launch and including launch CMS payer that CE commercial commercial policy Mark months still adoption. have ramping the of EX said, there codes meaningful of
on We believe are drive Together, deliver adoption our collaboration plan and execute pleased with growth Ascensia’s launch and accomplishments to with patient to we over work our expectations. we our time. as these positioned
for in as As is responsible approvals, manufacturing. reminder, development, well R&D, our collaboration, regulatory Senseonics clinical as a
Ascensia driving responsible business and for closely sales is operations. We sales, the collaborate marketing forward. on
CGM efficiency As manufacturing and Senseonics we our X-year advance include launch, distributors, support our while technology. on towards priorities to operational implantable advancing and our pipeline focusing Ascensia
the actively drive Together, community system and excited both are making and while about introduce through adoption support ensuring the meaningful Our are access from policies patient we opportunity diabetes growth awareness, insurance together. EX the health product partner the providers. engaging to coverage patient investments technology is to to our increase positive to
split finalized. launch outside million, Senseonics million are of U.S. been the quarter, revenue receiving of $X.X second are With which the have $X.X launch from systems. distribution the holding our from Channel of The States. generated inventory included partners EX, HCPs United initiation between logistics U.S. million underway, commercial $X.X in U.S. the and and the total
X-month only and sensors product. are been to We shipping now current commercial has our base EX completely transitioned the
unit platforms as progress Eversense was the roles, hires utilizing Ascensia side, Product This strong the EX. advertising by theater in are sales they the direct-to-consumer progress basis Ascensia making for on potential side feedback diabetes inside and at received at Eversense On increase ADA and new awareness and on is been presentations patient Engagement prescribers. the We key has positive and calling their have social their featuring campaigns, per built educators measured sales coverage. awareness and and the campaign The business progress. cost the field sales in on proven The current and make force sales interest management, with is sales ADC geographies diabetes media in by insertion conference to onboarded U.S. lead booth managers, this well patient and to product trained spearheaded dedicated and customer-facing June. territory new is being the a digital initial specific professionals. CGM the out the demonstrations. have excitement generation and brand demand tied targeting with as were in point, regions their demand to effectively and product the in HCP From in the clear coverage. continues community increasing HCPs At
transitioning pleased with existing mix patients help and the patients with overall an Eversense lead users, of our view of are leads new other CGM. the market. growing as CGMs potential a funnel take patient insertions goal and to being upgrading We the to grow encouraging users. early generation Recent sign represent from and and market this We share
users. will interested converting be focused increasing key Eversense partner growth. leads of number Our an now execution this Successful into these on on for is
issued coverage. policy and development, EX X, effective that to payer most transition eligible all front, G-code, a we transition will CMS coming which quarters, July expect this the have X-month And Medicare over to continue access very for beneficiaries. to payers past patient the access providing important X-month became product On coverage progressed, the to
second XXX we under for our over is With beneficiaries health products majority representing million to these provide now to adult million have U.S. codes covered total attention lives is the the in EX, in to a Eversense, eligible Ascensia ensure all with patients Anthem covered EX. large approximately access another their insurance XX of bringing In the covering working these place, turning lives largest validation to our max the of of provider our to U.S. value now population. adds codes.
We they working are next to that the roughly Eversense Anthem excited this from with over as system decision to in lives implement quarter. covered progress policy can in increasing the look see the and forward their benefit
making our and working build establish work capabilities, to are together at organizations we series more As a out targeted Eversense the to of programs launch also accessible.
and to a first commercial has to UCXgo a mentioned as now business procedure regional for about with setting. home forward provides done, developments. UCXgo convenient its mobile patient’s people the completed insertions of have programs and medical Texas. and provide of to importantly, potential we we medical and We is introducing which updating expand this considerations further an we and medical patients as care care the insertions. their new in such scalable UrgentCareXgo UCXgo’s to as partnership, as UCXgo workflow as users new to approaches engage by patient These accomplished mobile in regional insertions practice and appointment see environments. program, for previously pilot model the new some pool identified the as product other options product have We home urgent physician We needs insertion. from as as areas our news UCXgo Through meet go and clinics in-home effective, quality or and business safe medical to approach insertion look we in within various and their clinics these their Eversense local many have opportunities provides more multiple clinics, to learn product in HCPs about convenient options. the has well you for our include collaborations support.
first just Ascensia on system enables and achieved markets launched Europe. regional Europe update, benefits incorporate where efficiencies. been transition. generation calibration tender important of all chemistry Patients we year, X-year in design. the offers they are inventory their valuable for across that continues expand In trains EX by over and advanced exceptional begun developments be being of market. and have CGM available to pipeline, campaigns milestone, manufacturing operational contacted markets all CE underway in available focused Europe the Mark are will with the go-to-market access be accuracy uptake studies and to in our to reduced will sustained our first ongoing EX into to appointments phases have their The winning preparation features product worldwide of and transitioning This patients can requirements, each system well improving our our optimizing insertions enhancing work EX Further Eversense Europe, of product for the their and In time. will Ascensia supply with in with collateral. work for Arrangements the we pilot product actively Germany, soon be the in the incremental most Germany. enhanced important to schedule remainder EX same the completed in the which and to chain, June, marketing product service throughout Now marketing information new sensor, sales market as on force and the have provided efforts our launch continues of on goal on their as tenders process. other focusing In parts approach approval this
were Some results in of June. shared the these ADA at meeting
the are to configuration plan to on advancement data and our we studies year. trial recently recent of support a gathering year. pivotal a currently We the in next planned early excited these the iCGM FDA additional end pilot about Furthermore, clinical at are filing start approved
a We’re the patients delivery to system long be devices. insulin with excited variety about able life of wider potential for the integrate to Eversense our
in and digital connectivity we advances are the to as well. addition on making the sensor longevity front improvements iCGM, In the
share This CGM to for Eversense share the Apple providers helps Eversense in apps greater and will combine and with single and to turn their During call by available our our with patients details financial advance digital and other patients multiple as data Eversense combine data allows other patients the data sources quarter X go the the diabetes. over through believe we managing of their to coming data information quarters. now CGM expanded Nick we results. of step identify and I’ll patients the their apps making across on value provides additional capabilities their sensor We their sharing to second quarter, providers, continue over Health. valuable with is correlations significant partners a in to gain and a to integrated sources accessibility ability third-party to and insight data months data data
